Lung Cancer News and reporting on lung cancer. Nov 4, 2022 Lumakras Sales More Than Double in Q3 2022 as Amgen's Overall Revenues Decline 1 Percent Premium Nov 1, 2022 Monte Rosa Doses First Patient in Phase I/II Trial of MRT-2359 Oct 26, 2022 Yale Spinout Modifi Biosciences Nets $2.4M From NCI to Advance Targeted Cancer Drugs Toward Clinic Oct 25, 2022 ImaginAb Doses First Patient in Study of CD8-Targeted PET Imaging Agent in Australia Oct 13, 2022 CorriXR Therapeutics Spins Off From ChristianaCare to Develop CRISPR Cancer Therapies Oct 10, 2022 Iovance Biotherapeutics Doses First Patient in Modified TIL Therapy Trial Oct 7, 2022 Lyell Immunopharma to Begin Phase I Trial of Enhanced TIL Therapy LYL845 Oct 3, 2022 Theseus Pharmaceuticals to Develop Pan-EGFR Inhibitor for Resistant NSCLC Patients Sep 27, 2022 Thermo Fisher Gets FDA OK for CDx Test to Guide Use of Lilly Drug in Lung, Thyroid Cancers Sep 27, 2022 Optellum Raises $14M in Series A Financing Sep 22, 2022 Persephone Biosciences Enrolls First Patient in Study of Microbiome Effect on Cancer Drug Response Sep 20, 2022 Transcriptomics Plus 'Immune Tolerance' of Normal Tissue Shows Promise in Lung Cancer Prognosis Premium Sep 11, 2022 Repeat Biomarker Testing Informs Next Steps for Treatment-Resistant EGFR-Mutant NSCLC Patients Premium Sep 10, 2022 BMS Combo Drug Opdualag Effective in Neoadjuvant NSCLC, But Maybe No Better Than Opdivo Alone Premium Sep 6, 2022 Monte Rosa to Begin Phase I/II Trial of MRT-2359 in MYC-Driven Solid Cancers Sep 2, 2022 Jacobio Pharma Doses First NSCLC Patient in JAB-21822 Trial in China Sep 1, 2022 UPenn Studying Telehealth Impact on Timely Cancer Sequencing, Personalized Therapy in Lung Cancer Premium Aug 31, 2022 Amgen's Lumakras Bests Chemo, Meets Primary Endpoint in CodeBreak 200 Trial Aug 31, 2022 Oncocyte Nets $3M VA Contract for DetermaRx Lung Cancer Prognostic Test Aug 29, 2022 RedCloud Begins Phase I/IIa Trial in EGFR TKI-Resistant Lung Cancer Load More Breaking News Enhertu Shows Activity in Early-Stage HER2-Low Breast Cancer Patients in Study Reported at SABCS Dragonfly Therapeutics Begins Phase II Trial of HER2-Targeted NK-Cell Engager Touchlight to Provide DNA Vector for Odimma Therapeutics' Personalized Neoantigen Vaccine Trial FDA Approves Thermo Fisher HLA Typing Test as CDx for Immunocore Uveal Melanoma Therapy Caris Life Sciences, Hummingbird Bioscience Partner on Anti-HER3 Therapy Advancement Akeso, Summit Therapeutics Ink $5B Licensing Deal for PD-1/VEGF Bispecific Antibody
